Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Approvals
19 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Drug Approval
Qtrilmet Approved in the EU for the Treatment of Type-2 Diabetes
PR-M11-19-NI-020
Acquisition
Shire’s Takhzyro Sales Soar
PAO-M11-18-NI-015
FDA Approval
AbbVie Receives U.S. FDA Approval of ORILISSA™ (elagolix) for the Management of Moderate to Severe Pain Associated with Endometriosis
PR-M07-18-NI-078
Clinical Trials
CStone's PD-1 inhibitor CS1003 receives clinical trial approval in China
PR-M07-18-NI-042
Approvals
Japan Approves Two New AstraZeneca Cancer Meds
PAO-M07-18-NI-001
Drug Approval
WuXi STA First CDMO to Support the Approval of an Innovative Drug in China Through the "MAH" Pilot
PR-M06-18-NI-057
Treatment
New Single-Pill HIV Treatment Approved in Europe
PAO-M05-18-NI-015
Drug Delivery
Allergan Announces Launch of the TrueTear® Intranasal Neurostimulation Device During 2018 ASCRS-ASOA Annual Meeting
PR-M04-18-NI-55
Approval
Amgen Gets Expanded Approval for Blincyto®
PAO-M04-18-NI-005
Cell and Gene Therapy
New Stem Cell Therapy Approved in Europe
PR-M03-18-NI-102
Approval
GSK Announces Positive EU Approval for Labelling Update to Relvar Ellipta in Patients with Asthma
PR-M03-18-NI-048
Approval
Celltrion Receives EU Approval for Trastuzumab Biosimilar
PR-M02-18-NI-71
Approval
The Bruker MALDI Biotyper Solution Receives AOAC International Approvals for Two Official Methods of Analysis (OMA) in Food Microbiology
PR-M02-18-NI-65
Approval
LYNPARZA® (olaparib) Receives Approval in Japan for the Treatment of Advanced Ovarian Cancer
PR-M01-18-NI-078
Added Capacity
World’s Largest Biologics Plant Gets EMA Nod
PAO-M12-17-NI-029
Formulation
Polyphor AG: Polyphor Launches the Development of an Inhaled Formulation of its Antibiotic Murepavadin
PR-M10-17-NI-004
EMA Approves Continuous Manufacture of Prezista
PAO-M07-17-NI-002
Biosimilar
Biosimilar Manufacturers Get Favorable Decision from US Supreme Court
PAO-M06-17-NI-017
Biosimilar Era Begins to Blossom
PAO-M04-17-NI-027